Search for Clinical Trial Results
Glycogen Storage Disease Type I - 42 Studies Found
Status | Study |
Recruiting |
Study Name: Pompe Disease Registry Condition:
|
Completed |
Study Name: Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe Disease Condition:
|
Approved for marketing |
Study Name: Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Infantile-onset Pompe Disease Condition:
|
Completed |
Study Name: Extension Study of Long-term Safety and Efficacy of Myozyme in Patients With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored Enzyme Replacement Therapy (ERT) Studies Condition:
|
Completed |
Study Name: Extension Study of Long-term Safety and Efficacy of Myozyme for a Single Patient With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored ERT Studies. Condition:
|
Completed |
Study Name: A Study to Evaluate the Effects of Pharmacological Chaperones in Cells From Patients With Pompe Disease Condition:
|
Completed |
Study Name: An Exploratory Study of the Safety and Efficacy of Prophylactic Immunomodulatory Treatment in Myozyme-naive Cross-Reacting Immunologic Material (CRIM[-]) Patients With Infantile-Onset Pompe Disease Condition:
|
Completed |
Study Name: A Study of the Safety and Pharmacokinetics of rhGAA in Siblings With Glycogen Storage Disease Type II Condition:
|
Recruiting |
Study Name: NeoGAA Extension Study Condition: Glycogen Storage Disease Type II Pompe Disease Date: 2013-12-04 Interventions: Drug: GZ402666 Pharmaceutical form:lyophilized powder reconstituted for infusion Route of administration |
Completed |
Study Name: Newborn Screening Assay of Pompe's Disease Condition: Pompe Disease Date: 2008-07-09 Interventions: Other: Pompe disease newborn screening DBS will be tested for acid alpha-glucosidase (GAA)activity. Newb |